OVO

alcohol-dependent patients received naltrexone, acamprosate or placebo for 12 weeks. [1] there were no differences in outcomes between treatment groups [2] irrespective of actual treatment, perceived medication allocation predicted health outcomes.

Learning More About The Placebo Effect